PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S.
Zanoni L, et al.
Semin Nucl Med. 2023 May;53(3):320-351. doi: 10.1053/j.semnuclmed.2022.11.001. Epub 2022 Dec 14.
Semin Nucl Med. 2023.
PMID: 36522191
Review.
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical courses, varying from indolent to highly aggressive. (18)F-FDG-PET/CT is the current state-of-the-art diagnostic imaging, for the staging, res …
Non-Hodgkin lymphomas represents a heterogeneous group of lymphoproliferative disorders characterized by different clinical co …